BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26530448)

  • 1. Comparative plasma disposition kinetics of albendazole and its new benzimidazol prodrug in dog.
    Khalil Z; El Karbane M; Faouzi ME; Ansar M; Azougagh M; El Harti J; Taoufik J
    Ann Pharm Fr; 2016 Jan; 74(1):21-6. PubMed ID: 26530448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition kinetics of albendazole and metabolites in laying hens.
    Bistoletti M; Alvarez L; Lanusse C; Moreno L
    J Vet Pharmacol Ther; 2013 Apr; 36(2):161-8. PubMed ID: 22533477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative plasma disposition kinetics of albendazole, fenbendazole, oxfendazole and their metabolites in adult sheep.
    Lanusse CE; Gascon LH; Prichard RK
    J Vet Pharmacol Ther; 1995 Jun; 18(3):196-203. PubMed ID: 7674455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified plasma and abomasal disposition of albendazole in nematode-infected sheep.
    Alvarez LI; Sánchez SF; Lanusse CE
    Vet Parasitol; 1997 May; 69(3-4):241-53. PubMed ID: 9195734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.
    Goudah A
    Vet Res Commun; 2003 Oct; 27(7):555-66. PubMed ID: 14609267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal distribution of albendazole metabolites following netobimin administration to cattle: relationship with plasma disposition kinetics.
    Lanusse CE; Gascon LH; Prichard RK
    J Vet Pharmacol Ther; 1993 Mar; 16(1):38-47. PubMed ID: 8478999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs.
    Gokbulut C; Bilgili A; Hanedan B; McKellar QA
    Vet Parasitol; 2007 Sep; 148(3-4):279-87. PubMed ID: 17673370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of feeding on the plasma disposition kinetics of the anthelmintic albendazole in laying hens.
    Bistoletti M; Alvarez L; Lanusse C; Moreno L
    Br Poult Sci; 2014; 55(6):824-9. PubMed ID: 25159169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetic behaviour in sheep.
    Alvarez LI; Sánchez SF; Lanusse CE
    J Vet Pharmacol Ther; 1999 Apr; 22(2):77-86. PubMed ID: 10372592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albendazole sulphoxide kinetic disposition after treatment with different formulations in dogs.
    Dib A; Palma S; Suárez G; Farías C; Cabrera P; Castro S; Allemandi D; Moreno L; Lanusse C; Sánchez Bruni S
    J Vet Pharmacol Ther; 2011 Apr; 34(2):136-41. PubMed ID: 21395604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys.
    Gokbulut C; Akar F; McKellar QA
    Vet J; 2006 Jul; 172(1):166-72. PubMed ID: 16772142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of netobimin, albendazole, and its metabolites in the pregnant rat: developmental toxicity.
    Cristòfol C; Navarro M; Franquelo C; Valladares JE; Carretero A; Ruberte J; Arboix M
    Toxicol Appl Pharmacol; 1997 May; 144(1):56-61. PubMed ID: 9169069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma disposition kinetics of albendazole metabolites in pigs fed different diets.
    Alvarez LI; Saumell CA; Sanchez SF; Lanusse CE
    Res Vet Sci; 1996 Mar; 60(2):152-6. PubMed ID: 8685537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent activity of albendazole against benzimidazole-resistant nematodes in sheep: relationship between pharmacokinetics and efficacy.
    Moreno L; Echevarria F; Muñoz F; Alvarez L; Sanchez Bruni S; Lanusse C
    Exp Parasitol; 2004; 106(3-4):150-7. PubMed ID: 15172222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of serum pharmacokinetics and urinary excretion of albendazole and its metabolites in human volunteers.
    Ceballos L; Krolewiecki A; Juárez M; Moreno L; Schaer F; Alvarez LI; Cimino R; Walson J; Lanusse CE
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0005945. PubMed ID: 29346367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes.
    Gokbulut C; Cirak VY; Senlik B
    Vet Res Commun; 2006 Oct; 30(7):791-805. PubMed ID: 17004041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tissue residues of hydrochloric acid albendazole sulfoxide and its metabolites in crucian carp (Carassius auratus) after oral administration.
    Li Z; Chen C; Ai D; Wang C; Li J; Qi Y; Yi W; Shen H; Cao J
    Environ Toxicol Pharmacol; 2012 Mar; 33(2):197-204. PubMed ID: 22227164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional condition affects the disposition kinetics of albendazole in cattle.
    Sánchez SF; Alvarez LI; Lanusse CE
    Xenobiotica; 1996 Mar; 26(3):307-19. PubMed ID: 8730922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting-induced changes to the pharmacokinetic behaviour of albendazole and its metabolites in calves.
    Sánchez SF; Alvarez LI; Lanusse CE
    J Vet Pharmacol Ther; 1997 Feb; 20(1):38-47. PubMed ID: 9049948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of netobimin metabolites in pregnant ewes.
    Cristòfol C; Franquelo C; Navarro M; Carretero A; Ruberte J; Arboix M
    Res Vet Sci; 1997; 62(2):117-20. PubMed ID: 9243708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.